Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WHI Prempro Study Shows Need For Rx Marketing Restraint – Kessler On NPR

Executive Summary

The Women's Health Initiative study of Prempro illustrates the importance of restraining pharmaceutical company marketing practices, former FDA Commissioner David Kessler, MD, said during a National Public Radio commentary July 22
Advertisement

Related Content

Wyeth Sees Premarin Emerging Unscathed From WHI; Prempro Rxs Down 25%
Wyeth Sees Premarin Emerging Unscathed From WHI; Prempro Rxs Down 25%
Advertisement
UsernamePublicRestriction

Register

PS040245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel